Search for: "MERCK "
Results 941 - 960
of 3,283
Sort by Relevance
|
Sort by Date
27 Aug 2013, 12:46 pm
Merck has said that there are about 3,300 Fosamax femur fracture cases, and about 1,230 ONJ cases. [read post]
21 Aug 2013, 5:12 am
One cannot show nonobviousness by attacking referencesindividually where the rejections are based on combinations of references.In re Merck & Co., 800 F.2d 1091, 1097(Fed. [read post]
16 Aug 2013, 1:50 pm
Merck. [read post]
15 Aug 2013, 2:38 am
” The agency said it has already issued warning letters to 15 companies that are selling illegal diabetes products, some of which contained unapproved formulations of prescription medications such as Merck’s Januvia (sitagliptin). [read post]
12 Aug 2013, 3:58 pm
But the defendants did not have inventor testimony from anyone at Merck, and Judge Andrews found that there was no evidence that Merck had independently conceived of the invention. [read post]
12 Aug 2013, 2:06 pm
As regards Judge Sippel's ruling on Merck's motion for summary judgment, from this July 17, 2013 article, "Mo. [read post]
5 Aug 2013, 9:59 pm
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
4 Aug 2013, 5:30 am
http://t.co/qDmsnfGJFq -> Google reveals avalanche of link removal requests http://t.co/lWd2K4FgRa -> USPTO Again Rejects Apple’s Claim of Pinch-to-Zoom Patent http://t.co/YrME6CTcOi -> Four Tips from Merck’s $180M Patent Damages Win Against Apotex http://t.co/znvGmK3isO -> Google scholar link to FOX BROADCASTING COMPANY, INC. v. [read post]
1 Aug 2013, 9:29 am
• Liraglutide (Victoza) marketed by Novo Nordisk • Sitagliptin (Januvia, Janumet & Juvisync) marketed by Merck • Saxagliptin (Onglyza & Kombiglyze) marketed by Bristol-Myers Squibb in partnership with Astrazeneca • Alogliptin (Nesina, Kazano & Oseni) marketed by Takeda Pharmaceuticals • Linagliptin (Tradjenta & Jentadueto) marketed by Eli Lilly and Boehringer Ingelheim While the drug industry continues to ignore or deny the existence of… [read post]
30 Jul 2013, 1:34 pm
Januvia and Janumet, also manufactured by Merck, together earned $5.7 billion. [read post]
30 Jul 2013, 1:34 pm
Januvia and Janumet, also manufactured by Merck, together earned $5.7 billion. [read post]
30 Jul 2013, 1:34 pm
Januvia and Janumet, also manufactured by Merck, together earned $5.7 billion. [read post]
30 Jul 2013, 1:34 pm
Januvia and Janumet, also manufactured by Merck, together earned $5.7 billion. [read post]
30 Jul 2013, 5:30 am
http://t.co/qDmsnfGJFq -> Google reveals avalanche of link removal requests http://t.co/lWd2K4FgRa -> USPTO Again Rejects Apple’s Claim of Pinch-to-Zoom Patent http://t.co/YrME6CTcOi -> Four Tips from Merck’s $180M Patent Damages Win Against Apotex http://t.co/znvGmK3isO -> Google scholar link to FOX BROADCASTING COMPANY, INC. v. [read post]
28 Jul 2013, 9:29 am
For example, Merck makes both Januvia and Janumet, and last year alone enjoyed sales of nearly $6 billion while Novo’s Victoza generated $1.6 billion, and New York-based Bristol-Myers’s Byetta $149 million, according to data compiled by Bloomberg. [read post]
24 Jul 2013, 4:48 am
Additionally, Merck won an important court ruling for the entire pharmaceutical industry. [read post]
21 Jul 2013, 5:30 am
-> RT McCarthy Tétrault’s IP litigators win more than $180 million judgment for Merck against Apotex for infringing Merck’s lovastatin patent -> Irish Supreme court dismisses copyright appeal in software infringement case, Koger v O'Donnell [2013] IESC 28 http://t.co/hXZOznIAct -> Japanese government considering copyright term extension http://t.co/5MI5RAuQOH -> What does Canada’s new anti-spam law mean for individuals and businesses? [read post]
18 Jul 2013, 10:45 am
Way back in 1977, a plaintiff unsuccessfully sued the publisher of the Merck Manual. [read post]
10 Jul 2013, 7:44 am
This newly approved, updated prescribing information for ISENTERSS now includes 240-week results from the STARTMRK study, the double-blind Phase III study that evaluated integrase inhibitor in previously untreated adult patients with HIV-1 infection. [read post]
9 Jul 2013, 8:19 am
This past Monday, a New York federal judge denied Big Pharma’s Merck & Co Inc. [read post]
